The FDA and hypoglycemic drugs.
D000284:Administration, Oral / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000401:mortality*; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007880:Legislation, Drug; D010629:Phenformin / Q000009:adverse effects; D010919:Placebos; D014044:Tolbutamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D010919:Placebos; D014044:Tolbutamide; D010629:Phenformin